MetLife Investment Management LLC Lowers Stake in Lemonade, Inc. $LMND

MetLife Investment Management LLC lowered its stake in shares of Lemonade, Inc. (NYSE:LMNDFree Report) by 1.5% in the first quarter, HoldingsChannel.com reports. The firm owned 30,599 shares of the company’s stock after selling 469 shares during the period. MetLife Investment Management LLC’s holdings in Lemonade were worth $962,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in LMND. Vanguard Group Inc. boosted its position in shares of Lemonade by 14.9% during the 1st quarter. Vanguard Group Inc. now owns 6,138,444 shares of the company’s stock worth $192,931,000 after purchasing an additional 794,952 shares during the period. Two Sigma Investments LP purchased a new position in shares of Lemonade during the 4th quarter worth approximately $22,066,000. Voloridge Investment Management LLC purchased a new position in shares of Lemonade during the 4th quarter worth approximately $21,310,000. Two Sigma Advisers LP purchased a new position in shares of Lemonade during the 4th quarter worth approximately $15,412,000. Finally, Analyst IMS Investment Management Services Ltd. purchased a new position in shares of Lemonade during the 1st quarter worth approximately $9,944,000. Hedge funds and other institutional investors own 80.30% of the company’s stock.

Insiders Place Their Bets

In other news, COO Adina Eckstein sold 5,000 shares of the firm’s stock in a transaction on Tuesday, August 5th. The shares were sold at an average price of $49.00, for a total value of $245,000.00. Following the sale, the chief operating officer directly owned 189,653 shares in the company, valued at approximately $9,292,997. This trade represents a 2.57% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider John Sheldon Peters sold 2,718 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $50.34, for a total transaction of $136,824.12. Following the completion of the sale, the insider owned 102,397 shares in the company, valued at $5,154,664.98. The trade was a 2.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 19,543 shares of company stock worth $915,455 over the last 90 days. Company insiders own 14.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on LMND. Cantor Fitzgerald raised shares of Lemonade to a “strong-buy” rating in a research report on Wednesday, August 13th. BMO Capital Markets increased their target price on shares of Lemonade from $23.00 to $42.00 and gave the stock an “underperform” rating in a report on Monday, August 18th. Piper Sandler reiterated a “neutral” rating and set a $55.00 target price on shares of Lemonade in a report on Thursday, August 14th. Morgan Stanley reiterated an “underweight” rating on shares of Lemonade in a report on Monday, August 18th. Finally, Keefe, Bruyette & Woods reiterated an “underperform” rating and set a $26.00 target price (up from $22.00) on shares of Lemonade in a report on Tuesday, July 1st. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has given a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $40.43.

View Our Latest Research Report on LMND

Lemonade Trading Down 0.9%

Shares of LMND opened at $50.22 on Friday. Lemonade, Inc. has a twelve month low of $15.27 and a twelve month high of $60.41. The firm’s fifty day simple moving average is $46.67 and its 200-day simple moving average is $38.03. The firm has a market capitalization of $3.71 billion, a price-to-earnings ratio of -17.75 and a beta of 2.28.

Lemonade (NYSE:LMNDGet Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($0.60) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.81) by $0.21. Lemonade had a negative net margin of 33.96% and a negative return on equity of 36.12%. The business had revenue of $164.10 million for the quarter, compared to analyst estimates of $160.88 million. During the same period last year, the business earned ($0.81) EPS. The company’s revenue was up 34.5% on a year-over-year basis. Lemonade has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts predict that Lemonade, Inc. will post -3.03 earnings per share for the current fiscal year.

About Lemonade

(Free Report)

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.

Read More

Want to see what other hedge funds are holding LMND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lemonade, Inc. (NYSE:LMNDFree Report).

Institutional Ownership by Quarter for Lemonade (NYSE:LMND)

Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.